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012.09.0Abstract Despite advances in therapy, infective endocarditis (IE) remains a serious disease with high
mortality.We evaluated 155 Egyptian patients with Duke deﬁnite/possible IE to determine incidence,
causes and predictors of inhospital mortality. The mean time from symptoms onset to diagnosis was
66.4 ± 97 days. The causes of mortality (38.7%) included congestive heart failure (CHF), sepsis,
surgery related, stroke, cerebral hemorrhage, pulmonary embolism, sudden cardiac death, and
hyperkalemia. Predictors of mortality on univariate analysis were duration of symptoms before
hospital admission (p= 0.017), health care associated endocarditis (p= 0.039), CHF (p< 0.001),
fulminant sepsis (p< 0.001), embolization (p= 0.011), need for dialysis (p= 0.003), need for cardiac
surgery (p= 0.027), unperformed indicated cardiac surgery (p= 0.002) and higher C-reactive
protein level (p= 0.05). In multivariate analysis, only CHF remained an independent predictor of
mortality (p= 0.033). IE mortality was high in this cohort probably due to delayed diagnosis.
Patients having these mortality predictors especially CHF deserve more aggressive treatment.
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02and potentially curative surgery. Despite these improvements
in health care, the incidence of the disease remained un-
changed over the past two decades at approximately 1.7–6.2
cases per 100,000 patient years.1 Mortality in large series
ranges between 15% and 20%. Event-free long-term survival
in IE ranges from 17% to 67%.2 Cardiac complications, espe-
cially CHF and the need for late valve surgery after medically
treated infection, are the most frequent causes of morbidity
in IE.3,4
1. Methodology
Demographic, clinical, microbiologic, and echocardiographic
data of 155 consecutive patients with Duke deﬁnite/possibleg by Elsevier B.V. All rights reserved.
160 B. Al-Mogheer et al.IE in the Cairo University cardiology department IE database;
admitted in the period from Feb./2005 to Oct./2008 were ana-
lyzed retrospectively.
2. Results
2.1. Patient characteristics
The mean age of the patients was 32 ± 13 years. Native valve
IE represented (76.1%), while prosthetic valve IE represented
(23.9%). Health care associated IE was noted in (34.8%),
while IV drug abusers represented (7.7%). The mitral valve
(MV) was the most affected valve in 61 patients (39.4%), 45
of whom had native MV and 16 had MV prosthesis, followed
by aortic valve (AoV) in 47 patients (30.3%), 36 of whom had
native AoV, 8 had AoV prosthesis and one patient had AoV
bioprosthesis. Both valves were affected in 24 patients
(15.5%); in 13 of these patients both aortic and mitral valves
were native while in only one patient both were prosthetic.
The tricuspid valve (TV) was affected in 15 patients (9.7%).
In hospital complications occurred in 85.5% of patients.
2.2. Microbiology
In 60.6% of patients, organisms were identiﬁed by blood cul-
ture, surgical excised tissue culture or serology (48.4%, 6.5%
and 5.1%, respectively). The most common organism was
staphylococci (21.9%), followed by streptococci (8.4%). The
organism could not be identiﬁed by blood/tissue cultures or
serology in 39.4% of patients.
2.3. Cardiac complications
Severe valve regurgitation/leaﬂet perforation was detected in
40% of patients. Chordal rupture was detected in 3.9% of pa-
tients. Aortic root abscess with or without ﬁstula occurred in
7.7% of patients with only one patient developing mycotic
aneurysm of ascending aorta. In prosthetic valve IE prosthesis
dehiscence/paravalvular leak or both occurred in 28.4% while
prosthesis malfunction/stuck valve occurred in 1.9% of pa-
tients. CHF occurred in 49.7% of patients. One patient devel-
oped complete heart block (CHB).
2.4. Extra-cardiac complications
Systemic embolization occurred in 38.7% of patients. CNS
embolism occurred in 19.4% of patients. Splenic infarcts were
more frequent than splenic abscesses (8.4% and 3.2%, respec-
tively). Fulminant sepsis occurred in 10.3% of patients. Other
CNS complications as intracranial hemorrhage and cerebral
vessels mycotic aneurysms occurred in 7.7% and 5.2% of pa-
tients respectively. Dialysis was required in 7.1% of patients.
2.5. Mortality
Sixty patients (38.7%) died during the hospital stay. Causes of
death were CHF (23.3%), sepsis (20%), surgery related
(13.3%), stroke (10%), cerebral hemorrhage (6.6%), pulmon-
ary embolism (5%), sudden cardiac death (SCD) (1.7%), and
hyperkalemia (1.7%), while the cause of death was undeter-
mined in 18.3%.2.6. Surgical treatment
Although early cardiac surgery was indicated in 80.6% of pa-
tients (n= 125); they were performed in only 61.6% of pa-
tients (n= 77). Indications of cardiac surgery were severe
valvular lesion (47.1%), CHF (34.8%), large vegetations
(30.3%), uncontrolled infection (29%), prosthetic IE (20%),
aortic root abscess (14.2%) and recurrent embolism (13.5%).
Most common causes of non performance of indicated cardiac
surgery were patient death before surgery (17.6%), co-morbid-
ities (uncontrolled CHF, liver cell failure, acute stroke, cere-
bral hemorrhage, or multiple lung abscesses) (9.6%), patient
refusal of surgery (5.6%), surgeon refusal of surgery (2.4%)
and unavailable homograft (0.8%).
2.7. Predictors of mortality
2.7.1. Clinical predictors
Predictors of mortality identiﬁed on univariate analysis as
shown in Table 1 were duration before admission
(p= 0.017), HAE (p= 0.039), CHF (p=<0.001), fulminant
sepsis (p=<0.001), embolization (p= 0.011), need for
dialysis (p= 0.003), need for cardiac surgery (p= 0.027),
not performing indicated cardiac surgery (p= 0.002), and
higher C-reactive protein level (p= 0.05).
2.7.2. Microbiological and echocardiographic predictors
 There was no signiﬁcant difference between patients
who survived and those who died as regards the causa-
tive microorganism (p= 0.056).
 Echocardiographic parameters namely, valve affected
(p= 0.724), valve side affected (p= 0.192), native/
prosthetic IE (p= 0.81), and echocardiographic cardiac
complications (p= 0.133) were found not signiﬁcant as
a predictor of mortality in IE patients.
2.8. Logistic regression analysis of the predictors of mortality
By multivariable analysis, only CHF remained an independent
predictor of mortality (OR = 4.571; 95% CI, 1.134 to 18.43;
p= 0.033).
2.9. Discussion
Despite the improvement in the diagnosis and treatment of IE,
it still has a high morbidity and mortality, and hence the need
to identify high risk patients.
In our study, only CHF remained an independent predictor
of mortality by multivariate analysis adjusting for different
other variables. Heart failure is a recognized contributing fac-
tor in the mortality of IE as shown in several studies. In a study
by Heiro et al.,5 CHF was a statistically signiﬁcant predictor of
both in hospital and one year mortality. Nadji and colleagues6
in a recent study showed that CHF was independently predic-
tive of inhospital and 1 year mortality in left-sided native valve
IE. San Roma´n et al.,7 identiﬁed three independent risk factors
obtained within 72 h of admission, (Staphylococcus aureus,
heart failure and periannular complications) for inhospital
mortality or urgent surgery in a series of 317 IE patients.
Table 1 Clinical predictors of mortality in IE.
Mortality (n= 60) Survival (n= 95) p-value
Gender
Male 32 28 0.414
Female 57 38
Age 33.36 ± 13.12 31.22 ± 13.29 0.334
Duration (days)before admission 45.49 ± 47.85 79.16 ± 115.75 0.017
IVDU 7 5 0.216
HAE 27 27 0.039
Indicated for surgery 54 72 0.027
Surgery performed 21 58 0.002
CRP (Max.) 78 ± 61.98 49.62 ± 41.18 0.05
CHF 42 35 <0.001
Fulminant sepsis 15 1 <0.001
Systemic embolism 31 29 0.008
CNS embolism 16 14 0.059
Splenic abscesses 2 3 1.0
Splenic infarcts 4 9 0.767
IC hemorrhage 5 7 0.712
Mycotic aneurysms 3 5 1.0
Max creatinine >1.5 mg/l 28 36 0.874
Need for dialysis 9 2 0.003
Statistical signiﬁcance was established at p 6 0.05.
IVDU: intravenous drug use. HAE: health care associated endocarditis. CRP: C-reactive protein.CNS: central nervous system. IC: intracranial.
Max: maximum.
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dictors of mortality by univariate analysis namely duration
of symptoms before hospital admission, health care associated
endocarditis, fulminant sepsis, systemic but not CNS emboli-
zation, need for dialysis, need for cardiac surgery, unper-
formed indicated cardiac surgery and higher C-reactive
protein level . Sepsis was identiﬁed as a signiﬁcant predictor
of one year mortality in the study by Nadji et al.6 Embolic
events were also found to be a statistically signiﬁcant indepen-
dent predictor of both in hospital and one year mortality in
studies by Chu et al.8 and Heiro et al.5 High CRP values
(P100 mg/l) on admission signiﬁcantly predicted both short-
term and 1-year mortality in Heiro et al. study. This study
showed that an increment of 50 mg/l of CRP on admission is
associated with a statistically signiﬁcant 1.33-fold hazard for
in hospital death and a 1.24-fold hazard for death within
1 year from admission.5 Non performance of indicated cardiac
surgery was shown to be an independent predictor of mortality
in a study by Hoen et al.9 On the other hand, early surgery was
signiﬁcantly associated with a lower overall mortality rates in
Heiro et al. study.10 It was also a signiﬁcant predictor of im-
proved survival in two other studies.6,11 Concordant to the re-
sults of our study, nosocomial IE was associated with higher
mortality in 2 different studies.1,12. Renal co-morbidities either
as chronic renal failure or acquired as a complication to IE
were shown in many studies to be related to mortality.13,14
This study showed that the causative microorganism did
not predict mortality and this may be explained by the high
incidence of culture/ tissue/ serology negative (40%), leading
to a relatively small number of patients with identiﬁed individ-
ual microorganisms. This is similar to the results of Smith et al.
in which there was no mortality difference in the light of infect-
ing organism.14 In some studies, however, staphylococci(9) andin particular staphylococcus aureus were identiﬁed as indepen-
dent mortality predictor.8,15
This study also showed that echocardiographic characteris-
tics did not predict mortality, a ﬁnding in accordance with the
results of Chu et al. study.8
Age was not detected as a signiﬁcant predictor of mortality
in our study, a ﬁnding which is not consistent with several
other studies.5,16,17 This could be explained by the fact that
most of our patients were young (mean age 33.4 ± 13.1 and
31.2 ± 13.3 in the mortality and survival groups respectively)
as a result of the high prevalence of rheumatic valvular affec-
tion early in life in our country.
This study has some limitations. It was performed in a ter-
tiary care center and was hence, subject to a referral bias. The
high rate of culture/tissue/serology negative IE (40%) and the
relatively small number of patients did not provide the study
with adequate power to demonstrate difference between IE
due to varying individual microorganisms and IE affecting dif-
ferent individual valves.
In conclusion; CHF was the most powerful predictor of
mortality in this study, other mortality predictors were long
duration before admission, HAE, fulminant sepsis, systemic
embolization, dialysis, higher CRP level, and non performance
of indicated cardiac surgery. These are important factors to
determine patients in need of more aggressive treatment or
interventions.
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